Literature DB >> 16034879

Open retropubic colposuspension for urinary incontinence in women.

M C Lapitan1, D J Cody, A M Grant.   

Abstract

BACKGROUND: Urinary incontinence is a common and potentially debilitating problem. Open retropubic colposuspension is a surgical treatment which involves lifting the tissues near the bladder neck and proximal urethra in the area behind the anterior pubic bones to correct deficient urethral closure.
OBJECTIVES: To assess the effects of open retropubic colposuspension for the treatment of urinary incontinence. SEARCH STRATEGY: We searched the Cochrane Incontinence Group specialised register (searched 30 June 2004)and reference lists of relevant articles. We contacted investigators to locate extra studies. SELECTION CRITERIA: Randomised or quasi-randomised controlled trials in women with symptoms or urodynamic diagnoses of stress or mixed incontinence that included open retropubic colposuspension surgery in at least one trial group. DATA COLLECTION AND ANALYSIS: Studies were evaluated for methodological quality and appropriateness for inclusion and data extracted by two of the reviewers. Trial data were analysed by intervention. Where appropriate, a summary statistic was calculated. MAIN
RESULTS: This review included 39 trials involving a total of 3301 women. Overall cure rates were 68.9% to 88.0% for open retropubic colposuspension. Two small studies suggest lower failure rates after open retropubic colposuspension than conservative treatment. Similarly, one trial suggests lower failure rates after open retropubic colposuspension compared to anticholinergic treatment. Evidence from six trials showed a lower failure rate for subjective cure after open retropubic colposuspension than after anterior colporrhaphy. Such benefit was maintained over time (RR of failure 0.51; 95% CI 0.34 to 0.76 before the first year, RR 0.43; 95% CI 0.32 to 0.57 at one to five years, RR 0.49; 95% CI 0.32 to 0.75 in periods beyond 5 years). In comparison with needle suspensions there was a lower failure rate after colposuspension in the first year after surgery (RR 0.66; 95% CI 0.42 to 1.03), after the first year (RR 0.48; 95% CI 0.33 to 0.71), and beyond five years (RR 0.32; 95% CI 15 to 0.71). Evidence from twelve trials in comparison with suburethral slings found no significant difference in failure rates in all time periods assessed. Patient-reported failure rates in short-, medium- and long-term follow-up showed no significant difference between open and laparoscopic retropubic colposuspension, but with wide confidence intervals. In two trials failure was less common after Burch (RR 0.38 95% CI 0.18 to 0.76) than after the Marshall Marchetti Krantz procedure at one to five year follow-up. There were few data at any other follow-up time.In general, the evidence available does not show a higher morbidity or complication rate with open retropubic colposuspension, compared to the other open surgical techniques, although pelvic organ prolapse is more common than after anterior colporrhaphy and sling procedures. AUTHORS'
CONCLUSIONS: The evidence available indicates that open retropubic colposuspension is an effective treatment modality for stress urinary incontinence especially in the long term. Within the first year of treatment, the overall continence rate is approximately 85-90%. After five years, approximately 70% patients can expect to be dry. Newer minimal access procedures like tension free vaginal tape look promising in comparison with open colposuspension but their long-term performance is not known and closer monitoring of its adverse event profile must be done. Laparoscopic colposuspension should allow speedier recovery but its relative safety and effectiveness is not known yet.

Entities:  

Mesh:

Year:  2005        PMID: 16034879     DOI: 10.1002/14651858.CD002912.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  17 in total

Review 1.  Regenerative medicine based applications to combat stress urinary incontinence.

Authors:  Hatim Thaker; Arun K Sharma
Journal:  World J Stem Cells       Date:  2013-10-26       Impact factor: 5.326

Review 2.  Urethral injection therapy for urinary incontinence in women.

Authors:  Vivienne Kirchin; Tobias Page; Phil E Keegan; Kofi Om Atiemo; June D Cody; Samuel McClinton; Patricia Aluko
Journal:  Cochrane Database Syst Rev       Date:  2017-07-25

Review 3.  Outcomes of Surgery for Stress Urinary Incontinence in the Older Woman.

Authors:  David R Ellington; Elisabeth A Erekson; Holly E Richter
Journal:  Clin Geriatr Med       Date:  2015-07-26       Impact factor: 3.076

Review 4.  Management of recurrent stress incontinence following a sling.

Authors:  Geneviève Nadeau; Sender Herschorn
Journal:  Curr Urol Rep       Date:  2014-08       Impact factor: 3.092

5.  Midurethral slings for women with stress urinary incontinence: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2006-02-01

6.  The distribution of different surgical types for female stress urinary incontinence among patients' age, surgeons' specialties and hospital accreditations in Taiwan: a descriptive 10-year nationwide study.

Authors:  Ming-Ping Wu; Kuan-Hui Huang; Cheng-Yu Long; Kuo-Feng Huang; Ken-Jen Yu; Chao-Hsiun Tang
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-08-12

Review 7.  Surgical management of female SUI: is there a gold standard?

Authors:  Ashley Cox; Sender Herschorn; Livia Lee
Journal:  Nat Rev Urol       Date:  2013-01-15       Impact factor: 14.432

Review 8.  [Treatment of female and male stress urinary incontinence. Current aspects].

Authors:  B Amend; C Reisenauer; A Stenzl; K-D Sievert
Journal:  Urologe A       Date:  2009-09       Impact factor: 0.639

9.  Stress urinary incontinence: Sling or colposuspension?

Authors:  Rajiv Paul Mukha; J Chandra Singh; Nitin S Kekre
Journal:  Indian J Urol       Date:  2007-10

10.  Surgery for stress urinary incontinence in women: A 2006 review.

Authors:  Bertil F M Blok; Jacques Corcos
Journal:  Indian J Urol       Date:  2007-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.